Trametinib
Back to search| Scientific Name: | Trametinib |
| Brand Name: | Mekinist |
| Company Owner: | Not Available |
| Mechanism Of Action | Trametinib is a reversible, allosteric inhibitor of mitogen-activated extracellular signal regulated kinase 1 |
| Description of the Drug: | Trametinib is a kinase inhibitor used to treat patients with specific types of melanoma, non-small cell lung cancer, and thyroid cancer. |
| Protein Data Bank: |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB08911
